Literature DB >> 28847643

Posterior Tibial Nerve Lymphoma Presenting as Tarsal Tunnel Syndrome: A Case Report.

Ali Moussa1, Zaher Chakhachiro2, Raja A Sawaya3.   

Abstract

We report a case of isolated posterior tibial B-cell lymphoma of the posterior tibial nerve presenting as tarsal tunnel syndrome. This diagnosis was considered because of the clinical presentation and electrophysiologic abnormalities. It was further confirmed by the magnetic resonance imaging findings of the ankle and tissue pathologic findings. Whole body positron emission tomography confirmed this to be a localized lymphoma involving the peripheral nerve. The patient underwent chemotherapy with complete tumor resolution. She had had no relapse after 8 months of follow-up. Isolated peripheral nerve lymphomas are very rare, and involvement of the posterior tibial nerve has not been previously reported. Furthermore, the present case report highlights the importance of the clinical examination in the diagnosis of tarsal tunnel syndrome before performing surgical decompression.
Copyright © 2017 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  electrophysiology; lymphoma; peripheral nerve; posterior tibial nerve; tarsal tunnel syndrome

Mesh:

Substances:

Year:  2017        PMID: 28847643     DOI: 10.1053/j.jfas.2017.07.004

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  2 in total

Review 1.  An Update on Posterior Tarsal Tunnel Syndrome.

Authors:  Luc M Fortier; Kenna N Leethy; Miranda Smith; Margaret M McCarron; Christopher Lee; William F Sherman; Giustino Varrassi; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

Review 2.  Neurolymphomatosis of the lumbosacral plexus and its branches: case series and literature review.

Authors:  Pierre R Bourque; Marcos Loreto Sampaio; Jodi Warman-Chardon; Sam Samaan; Carlos Torres
Journal:  BMC Cancer       Date:  2019-11-27       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.